Detalhe da pesquisa
1.
Tissue-infiltrating alloreactive T cells require Id3 to deflect PD-1-mediated immune suppression during GVHD.
Blood
; 143(2): 166-177, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871574
2.
Effective treatment of low-risk acute GVHD with itacitinib monotherapy.
Blood
; 141(5): 481-489, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36095841
3.
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies.
Genes Dev
; 31(10): 1007-1023, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28611190
4.
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Haematologica
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634143
5.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334852
6.
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; : 10781552231189199, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603585
7.
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(9): 1033-1062, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075392
8.
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
J Oncol Pharm Pract
; 28(4): 892-897, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191732
9.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
10.
Midostaurin improves quality of life and mediator-related symptoms in advanced systemic mastocytosis.
J Allergy Clin Immunol
; 146(2): 356-366.e4, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437738
11.
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
Blood
; 131(25): 2846-2855, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545329
12.
Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(9): 1248-1269, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886902
13.
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Am J Hematol
; 95(7): 792-798, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242967
14.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256954
15.
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 25(3): 515-521, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315941
16.
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
N Engl J Med
; 374(26): 2530-41, 2016 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27355533
17.
Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice.
Blood
; 129(20): 2737-2748, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28246193
18.
The splendor and the tyranny of JAK inhibition.
Haematologica
; 109(2): 369-370, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37822272
19.
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors.
Biol Blood Marrow Transplant
; 24(6): 1203-1208, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408506
20.
JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.
Br J Haematol
; 182(1): 78-85, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767839